Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Pulmonary Hypertension

Free Subscription 09.03.2026 1 Arthritis Rheumatol 1 Cells 1 Clin Transplant 1 Clin Transplant Res 1 Free Radic Biol Med 1 Int Immunopharmacol 1 Int J Mol Sci 1 J Perinat Med 1 J Pharmacol Exp Ther 1 Medicine (Baltimore) 2 Pediatr Cardiol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arthritis Rheumatol

1. YANG MM, Liu S, Wax M 2nd, Lee S, et al
   Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis.
   Arthritis Rheumatol. 2026;78:428-437.
   PubMed         Abstract available
   
   

   
   Cells

2. LIN Y, Wang A, Valdez-Jasso D
   Adventitial Fibrosis and Fibroblast Mechanosensitivity Are Shaped by Sex and Hormonal Status in Pulmonary Arterial Hypertension.
   Cells. 2026;15:354.
   PubMed         Abstract available
   
   

   
   Clin Transplant

3. MANSO TEJERINA P, Loaiza Q, Andres C, Margallo Iribarnegaray J, et al
   Impact of Pulmonary Veno-Occlusive Disease on Posttransplant Survival in Pulmonary Hypertension.
   Clin Transplant. 2026;40:e70493.
   PubMed         Abstract available
   
   

   
   Clin Transplant Res

4. BATHEJA V, Modasia B, Puri S, Meshram HS, et al
   Dual carrier status for HUPRA (hyperuricemia, pulmonary hypertension, renal failure, and alkalosis) syndrome and Wilson disease in a young dialysis patient: clinical and genetic counseling implications.
   Clin Transplant Res. 2026 Mar 5. doi: 10.4285/ctr.25.0071.
   PubMed        
   
   

   
   Free Radic Biol Med

5. LIANG Q, Wang Y, Zhang X, Guo D, et al
   Acox1 induces lipid peroxidation and metabolic shifting to promote PASMCs proliferation in hypoxia-induced pulmonary hypertension.
   Free Radic Biol Med. 2026;248:469-484.
   PubMed         Abstract available
   
   

   
   Int Immunopharmacol

6. JIANG R, Li L, Luo Y, Wang W, et al
   GM-CSF exacerbates pulmonary arterial hypertension via CCL2/CCR2-axis-mediated macrophage NLRP3 inflammasome activation.
   Int Immunopharmacol. 2026;174:116394.
   PubMed         Abstract available
   
   

   
   Int J Mol Sci

7. ONOFRE MESF, Santos RT, Rocha NN, Caldeira DAF, et al
   Mitochondrial Transplantation from Bone Marrow Mesenchymal Stromal Cells Combined with Sildenafil Attenuated Vascular Remodeling and Improved Right Ventricular Dysfunction in Experimental Pulmonary Arterial Hypertension.
   Int J Mol Sci. 2026;27:1761.
   PubMed         Abstract available
   
   

   
   J Perinat Med

8. VERMA S, Seltzer BHS, Fisher JC, Cicalese E, et al
   Outcomes in early term neonates requiring extracorporeal membrane oxygenation.
   J Perinat Med. 2025 Oct 20. doi: 10.1515/jpm-2025-0235.
   PubMed         Abstract available
   
   

   
   J Pharmacol Exp Ther

9. SUZUKAWA A, Hemmi R, Fujiwara M, Motomura T, et al
   Repositioning lidocaine as a TMEM16A Ca(2+)-activated Cl(-) channel blocker for the treatment of pulmonary arterial hypertension.
   J Pharmacol Exp Ther. 2026;393:103799.
   PubMed         Abstract available
   
   

   
   Medicine (Baltimore)

10. LIU S, Yuan H, Cao J, Cai L, et al
    Circulating fatty acid profiles and risk of pulmonary arterial hypertension: Evidence from a large prospective cohort study.
    Medicine (Baltimore). 2026;105:e47645.
    PubMed         Abstract available
    
    

    
    Pediatr Cardiol

11. TORUN EG, Ozdemiroglu N, Bagrul D, Ece I, et al
    Pulmonary Artery Pulsatility Index: A Novel Marker for Risk Assessment and Prognosis in Pediatric Idiopathic Pulmonary Arterial Hypertension.
    Pediatr Cardiol. 2026;47:1788-1797.
    PubMed         Abstract available
    
    
12. RODRIGUEZ OGANDO A, Sabate-Rotes A, Moya Bonora A, Albert de la Torre L, et al
    Macitentan in Children with Pulmonary Arterial Hypertension: A Multicenter Experience.
    Pediatr Cardiol. 2026;47:1572-1580.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum